Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioburden Reduction of Diabetic Foot Ulcer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2008 by Nomir Medical Technologies.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
Nomir Medical Technologies
ClinicalTrials.gov Identifier:
NCT00776854
First received: October 18, 2008
Last updated: October 20, 2008
Last verified: October 2008

October 18, 2008
October 20, 2008
November 2008
July 2009   (final data collection date for primary outcome measure)
Decrease of Bioburden Effect In diabetic Foot Ulcer [ Time Frame: 28 days ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Bioburden Reduction of Diabetic Foot Ulcer
Noveon Laser Treatment to Effect Bioburden Reduction or Elimination in Diabetic Foot Ulcer: A Davice Performance Clinical Study
Study to see if a laser can get rid of bacateria called MRSA in your diabetic ulcer
Not Provided
Interventional
Phase 1
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Diabetic Foot Ulcer
Device: Noveon laser
870 and 930nm wavelengths
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
20
November 2009
July 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 and older
  • Diabetic foot ulcer
  • MRSA positive

Exclusion Criteria:osteomylelitis pregnancy allery to e mycin

Both
18 Years to 70 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00776854
12.001a
Not Provided
Not Provided
Not Provided
Alan Robbin, M.D., Nomir Medical
Nomir Medical Technologies
Not Provided
Not Provided
Nomir Medical Technologies
October 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP